- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02312037
Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy (AML)
August 17, 2019 updated by: Pfizer
GEMTUZUMAB OZOGAMICIN (MYLOTARG (REGISTERED)) EXPANDED ACCESS PROTOCOL FOR TREATMENT OF PATIENTS IN THE UNITED STATES WITH RELAPSED/REFRACTORY ACUTE MYELOGENOUS LEUKEMIA WHO MAY BENEFIT FROM TREATMENT AND HAVE NO ACCESS TO OTHER COMPARABLE/ALTERNATIVE THERAPY
An expanded access/compassionate use protocol that allows access to Mylotarg for relapsed/refractory AML CD33 positive patients in the USA.
Contact: B1761026@iconplc.com
Study Overview
Status
No longer available
Conditions
Intervention / Treatment
Detailed Description
Contact:
B1761026@iconplc.com
Study Type
Expanded Access
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- University of Alabama at Birmingham/Children's of Alabama
-
-
Alaska
-
Anchorage, Alaska, United States, 99508
- Providence Alaska Medical Center
-
Anchorage, Alaska, United States, 99508
- Providence Cancer Center
-
Anchorage, Alaska, United States, 99508-2980
- Alaska Oncology & Hematology, LLC
-
-
Arizona
-
Mesa, Arizona, United States, 85202
- Banner Pediatric Specialists Hematology/Oncology Clinic
-
Mesa, Arizona, United States, 85202
- Cardon Children's Medical Center.
-
Phoenix, Arizona, United States, 85016
- Phoenix Children's Hospital
-
-
California
-
Los Angeles, California, United States, 90027
- Children's Hospital of Los Angeles - University of Southern California School of Medicine
-
Oakland, California, United States, 94611
- Kaiser Permanente - Oakland
-
Oakland, California, United States, 94611
- Kaiser Permanente - Oakland Medical Center
-
Orange, California, United States, 92868
- Children's Hospital of Orange County
-
Roseville, California, United States, 95661
- Kaiser Permanente - Roseville
-
San Diego, California, United States, 92123
- UCSD/ Rady Children's Hospital
-
Santa Clara, California, United States, 95051
- Kaiser Permanente - Santa Clara
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale University
-
New Haven, Connecticut, United States, 06510
- C/O Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven
-
New Haven, Connecticut, United States, 06510
- Smilow Cancer Hospital at Yale-New Haven
-
New Haven, Connecticut, United States, 06510
- Yale New-Haven Hospital & Smilow Cancer Center
-
Trumbull, Connecticut, United States, 06611
- Yale Medical Group
-
-
Delaware
-
Wilmington, Delaware, United States, 19803
- Nemours - A.I. duPont Hospital for Children
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Children's National Medical Center
-
-
Florida
-
Hollywood, Florida, United States, 33021
- Memorial Regional Hospital
-
Hollywood, Florida, United States, 33021
- Joe DiMaggio Children's Hospital
-
Hollywood, Florida, United States, 33021
- JDCH pediatric Oncology and Hematology
-
Jacksonville, Florida, United States, 32207-8426
- Nemours Children's Clinic
-
Jacksonville, Florida, United States, 32207
- Baptist Medical Center/Wolfson Children's Hospital
-
Orlando, Florida, United States, 32804
- Florida Hospital Cancer Institute
-
Orlando, Florida, United States, 32827
- Nemours Children's Hospital
-
Orlando, Florida, United States, 32804
- Cancer Institute Of Florida
-
Orlando, Florida, United States, 32804
- Blood and Marrow Transplant Center
-
Pembroke Pines, Florida, United States, 33021
- Memorial Cancer Institute at Memorial Hospital West
-
Pembroke Pines, Florida, United States, 33021
- Memorial Hospital West
-
Saint Petersburg, Florida, United States, 33701
- Johns Hopkins All Children's Hospital
-
Saint Petersburg, Florida, United States, 33701
- Johns Hopkins All Children's Hospital IDS Pharmacy
-
Saint Petersburg, Florida, United States, 33701
- Johns Hopkins All Children's Outpatient Care Pediatric Hematology/Oncology Department
-
Tampa, Florida, United States, 33612
- H.Lee Moffitt Cancer Center and Research Institute
-
-
Georgia
-
Atlanta, Georgia, United States, 30342
- Children's Healthcare of Atlanta at Scottish Rite
-
Atlanta, Georgia, United States, 30342
- Northside Hospital
-
Atlanta, Georgia, United States, 30322
- Children's Healthcare of Atlanta at Egleston
-
Atlanta, Georgia, United States, 30342-4790
- The Blood & Marrow Transplant Group Of Georgia
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Ann & Robert H. Lurie Children's Hospital of Chicago
-
Chicago, Illinois, United States, 60637
- University of Chicago Medical Center
-
Chicago, Illinois, United States, 60637
- The University of Chicago
-
Chicago, Illinois, United States, 60637
- The University of Chicago Medical Center
-
Chicago, Illinois, United States, 60637
- Investigational Drugs Service Pharmacy, Attn. Judy Pi, PharmD, Ami Patel, PharmD
-
Maywood, Illinois, United States, 60153
- Loyola University Medical Center
-
Maywood, Illinois, United States, 60153
- Cardinal Bernardin Cancer Center/Loyola University Medical Center
-
Maywood, Illinois, United States, 60153
- Loyola University Chicago, performing research at Loyola University Medical Center
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- IU Health Pharmacy
-
Indianapolis, Indiana, United States, 46237
- Indiana Blood and Marrow Transplantation
-
Indianapolis, Indiana, United States, 46202-5225
- Indiana University Riley Hospital for Children
-
Indianapolis, Indiana, United States, 46237
- Indiana Blood and Marrow Transplantation - Administrative Offices
-
Indianapolis, Indiana, United States, 46237
- St.Francis Hospital
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- University Of Kansas Hospital
-
Westwood, Kansas, United States, 66205
- University of Kansas Cancer Center
-
Westwood, Kansas, United States, 66205
- The University of Kansas Cancer Center and Medical Pavilion
-
Westwood, Kansas, United States, 66205
- The University of Kansas Cancer Center and Medical Pavillion
-
-
Kentucky
-
Lexington, Kentucky, United States, 40536
- UK Healthcare Markey Cancer Center
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins University
-
Baltimore, Maryland, United States, 21231
- Johns Hopkins University IDS Pharmacy
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
Mississippi
-
Southaven, Mississippi, United States, 38671
- The West Clinic, P.C. dba West Cancer Center
-
-
Missouri
-
Creve Coeur, Missouri, United States, 63141
- Siteman Cancer Center - West County
-
Kansas City, Missouri, United States, 64108
- Children's Mercy Hospital
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
Saint Louis, Missouri, United States, 63110
- Barnes-jewish Hospital
-
Saint Louis, Missouri, United States, 63129
- Siteman Cancer Center - South County
-
Saint Louis, Missouri, United States, 63110
- Washington University Infusion Center Pharmacy
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine, Siteman Cancer Center
-
-
New Jersey
-
New Brunswick, New Jersey, United States, 08903
- Rutgers Cancer Institute of New Jersey
-
New Brunswick, New Jersey, United States, 08901
- Robert Wood Johnson University Hospital
-
-
New York
-
Buffalo, New York, United States, 14263
- Roswell Park Cancer Institute
-
East Setauket, New York, United States, 11733
- North Shore Hematology Oncology Associates, P.C.
-
New York, New York, United States, 10065
- Memorial Sloan-Kettering Cancer Center
-
New York, New York, United States, 10021
- Weill Cornell Medical College - New York-Presbyterian Hospital
-
New York, New York, United States, 10065
- Weill Cornell Medical College - New York-Presbyterian Hospital
-
Rochester, New York, United States, 14642
- University of Rochester Medical Center
-
Rochester, New York, United States, 14642
- University of Rochester Cancer Center Pharmacy
-
-
North Carolina
-
Greenville, North Carolina, United States, 27834
- Vidant Medical Center
-
Greenville, North Carolina, United States, 27834
- Brody School of Medicine at ECU
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- University Hospitals of Cleveland Rainbow Babies & Children's Hospital
-
Columbus, Ohio, United States, 43205
- Nationwide Children's Hospital
-
-
Pennsylvania
-
Danville, Pennsylvania, United States, 17822
- Geisinger Medical Center
-
Hershey, Pennsylvania, United States, 17033
- Milton Hershey Medical Center
-
Philadelphia, Pennsylvania, United States, 19104
- The Children's Hospital of Philadelphia
-
Philadelphia, Pennsylvania, United States, 19107
- Thomas Jefferson University
-
Philadelphia, Pennsylvania, United States, 19134
- St. Christopher's Hospital for Children
-
Philadelphia, Pennsylvania, United States, 19107-4215
- Thomas Jefferson University (Tju) - Jefferson University Physicians (Jup)
-
Philadelphia, Pennsylvania, United States, 19107
- Thomas Jefferson University, Investigative Drug Service
-
Philadelphia, Pennsylvania, United States, 19107
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office (Clinical)
-
Philadelphia, Pennsylvania, United States, 19107
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office (Regulatory)
-
Pittsburgh, Pennsylvania, United States, 15224
- Allegheny Health Network, Cancer Institute, West Penn Hospital
-
-
Tennessee
-
Germantown, Tennessee, United States, 38138
- The West Clinic, P.C. dba West Cancer Center
-
Knoxville, Tennessee, United States, 37916
- East Tennessee Children's Hospital
-
Memphis, Tennessee, United States, 38105
- St. Jude Children's Research Hospital
-
Memphis, Tennessee, United States, 38120
- Baptist Memorial Hospital
-
Memphis, Tennessee, United States, 38120
- The West Clinic, P.C. dba West Cancer Center
-
Nashville, Tennessee, United States, 37203
- Sarah Cannon Research Institute
-
Nashville, Tennessee, United States, 37232
- Monroe Carell Jr. Children's Hospital at Vanderbilt
-
Nashville, Tennessee, United States, 37203
- Tennessee Oncology, PLLC
-
Nashville, Tennessee, United States, 37203
- The Children's Hospital at TriStar Centennial
-
Nashville, Tennessee, United States, 37203
- Tennessee Oncology - Nashville
-
Nashville, Tennessee, United States, 37203
- TriStar Centennial Medical center
-
Nashville, Tennessee, United States, 34203
- Sarah Cannon Research Institute
-
Nashville, Tennessee, United States, 37203
- Sarah Cannon Center for Blood Cancer
-
Nashville, Tennessee, United States, 37203
- TriStar Centennial Medical Center/Sarah Cannon Cener for Blood Cancer
-
Nashville, Tennessee, United States, 37203
- TriStar Medical Group Children's Specialist
-
Nashville, Tennessee, United States, 37212
- VA Tennessee Valley Healthcare System - Nashville Campus
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University Medical Center - The Vanderbilt Clinic
-
-
Texas
-
Austin, Texas, United States, 78723
- Dell Children's Medical Center of Central Texas
-
Austin, Texas, United States, 78723
- Dell Children's Medical Center
-
Austin, Texas, United States, 78723
- Children's Blood and Cancer Center
-
El Paso, Texas, United States, 79905
- El Paso Children's Hospital
-
El Paso, Texas, United States, 79905
- Texas Tech University Health Sciences Center
-
Fort Worth, Texas, United States, 76104
- Cook Children's Medical Center
-
Fort Worth, Texas, United States, 76104
- Cook Children's Hematology/Oncology Center
-
Grapevine, Texas, United States, 76051
- Cook Children's Hematology/Oncology Center - Grapevine
-
Houston, Texas, United States, 77030
- Texas Children's Hospital
-
Houston, Texas, United States, 77030
- Houston Methodist Hospital
-
Houston, Texas, United States, 77030
- Texas Children's Hospital Attn: Investigational Pharmacy Services
-
Houston, Texas, United States, 77584
- Houston Methodist Cancer Center
-
-
Utah
-
Salt Lake City, Utah, United States, 84113
- Primary Children's Hospital
-
Salt Lake City, Utah, United States, 84112
- Huntsman Cancer Institute-University of Utah
-
Salt Lake City, Utah, United States, 84112
- Huntsman Cancer Hospital
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- UVA Health System
-
Charlottesville, Virginia, United States, 22903
- Emily Couric Clinical Cancer Center
-
Charlottesville, Virginia, United States, 22903
- Cancer Center IDS Pharmacy Attn: Lauren Benusa, Pharm D.
-
Hampton, Virginia, United States, 23666
- Virginia Oncology Associates
-
Norfolk, Virginia, United States, 23507
- Children's Hospital of the King's Daughters
-
Virginia Beach, Virginia, United States, 23456
- Virginia Oncology Associates
-
-
Washington
-
Seattle, Washington, United States, 98105
- Seattle Children's
-
Seattle, Washington, United States, 98104
- Swedish Medical Center First Hill, IDS Pharmacy
-
Seattle, Washington, United States, 98105
- Seattle Children's IDS Pharmacy - Attn. Laura Winter
-
Seattle, Washington, United States, 98122
- Lisa Nakatsu, RPh
-
-
Wisconsin
-
Appleton, Wisconsin, United States, 59413
- Fox Valley Hematology & Oncology, SC
-
Green Bay, Wisconsin, United States, 54311
- Aurora BayCare Medical Center
-
Milwaukee, Wisconsin, United States, 53226
- Medical College Of Wisconsin
-
Milwaukee, Wisconsin, United States, 53226
- Children's Hospital of Wisconsin
-
Oshkosh, Wisconsin, United States, 59404
- Fox Valley Hematology & Oncology, SC
-
Wauwatosa, Wisconsin, United States, 53226
- Aurora Health Care, Aurora Cancer Care
-
West Allis, Wisconsin, United States, 53227
- Aurora Health Care, Aurora Cancer Care
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Confirmed diagnosis of relapsed/refractory AML (defined as >=5% marrow blasts by morphology), including MDS, with persisting rising blasts and no other comparable or satisfactory alternative therapy available. If bone marrow has <5% blasts by morphology but the patient has evidence of relapse with extra-medullary disease progression. In select cases presenting with conversion of MRD from negative to positive, treatment with GO may be allowed where no alternative treatments are feasible.
OR
- Confirmed diagnosis of relapsed or refractory APL with persisting or rising leukemic burden (either by morphology, cytogenetic analysis or by molecular techniques), and no other comparable or satisfactory alternative therapy available.
Documentation that malignant cells express CD33
4) Age >=3 months
5) Adequate non-hematologic organ function
Exclusion Criteria:
- Untreated AML and MDS or AML and MDS in complete remission.
- Patients with a known history of VOD/SOS.
- Patients with a known hypersensitivity to Mylotarg or its parts: hP67.6 antibody, calicheamicin derivatives or other ingredients.
- Participation in other studies involving investigational drug(s) (Phases 1-4) during study participation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
December 4, 2014
First Submitted That Met QC Criteria
December 4, 2014
First Posted (Estimate)
December 9, 2014
Study Record Updates
Last Update Posted (Actual)
August 20, 2019
Last Update Submitted That Met QC Criteria
August 17, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B1761026
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on CD33 Positive Acute Myelogenous Leukemia
-
Hoffmann-La RocheCompletedMyelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, AcuteUnited States, France, Canada
-
M.D. Anderson Cancer CenterActive, not recruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Accelerated Phase...United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedAccelerated Phase Chronic Myelogenous Leukemia | Adult Acute Lymphoblastic Leukemia in Remission | Childhood Acute Lymphoblastic Leukemia in Remission | Childhood Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Immunex CorporationWithdrawnAcute Myelogenous Leukemia | Chronic Myelogenous Leukemia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Therapy-Related Acute Myeloid Leukemia and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1... and other conditionsUnited States
-
Merck Sharp & Dohme LLCTerminatedLeukemia, Lymphocytic, Acute | Myelogenous Leukemia, Acute | Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Myelogenous Leukemia, Chronic, Aggressive Phase
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Acute Lymphoblastic Leukemia | Refractory Chronic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Acute Lymphoblastic Leukemia | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Bio-Path Holdings, Inc.WithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia, Ph1-PositiveUnited States
Clinical Trials on Antibody Drug Conjugate Chemotherapeutic
-
Central South UniversityCompletedAgranulocytosis | Opportunistic Infections | Sepsis (SMQ)China
-
MedImmune LLCCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Spain, Greece
-
Rahul AggarwalFortis Therapeutics, Inc.RecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Ambrx, Inc.CompletedBreast Neoplasms | Solid Tumors | Gastric NeoplasmUnited States, Australia
-
MBrace TherapeuticsRecruiting
-
Hangzhou DAC Biotechnology Co., Ltd.Not yet recruitingAdvanced Solid Tumors | Hematological Malignancies
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...RecruitingAdvanced/ Metastatic Solid TumorsChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...Not yet recruitingAdvanced and Metastatic Solid TumorChina